Curriculum Vitae. Robert Louis Drapkin, M.D., F.A.C.P. Clearwater Beach, FL

Transcription

1 Curriculum Vitae Robert Louis Drapkin, M.D., F.A.C.P. Board Certified Diplomate Internal Medicine (June, 1975) Diplomate Medical Oncology (June, 1979) Fellow American College of Physicians (April, 1981) Diplomate Hospice and Palliative Care (Feruary,2004) Date of Birth: 09/22/1944 Marital Status: Married Home Address and Telephone: 1003 Bay Esplanade Clearwater Beach, FL Office Addresses: 3280 McMullen Booth rd #200 Clearwater, FL fax CURRENT EMPLOYER FLORIDA CANCER SPECIALISTS 400 Pinellas Street, Suite 300 Clearwater, FL fax Colleges Attended Union College; Schenectady, New York: September 1962 to June 1966 (BS) Renssellaer Polytechnic Institute; Troy, New York: July 1966 to August 1967 (MS) Wayne State University Medical School; Detroit, Michigan: September 1967 to June 1971 (MD)

2 Hospital and Academic Appointments Medical Director, Stem Cell Program Morton Plant Hospital, Clearwater, FL Resident, Internal Medicine University of Illinois Hospital; Chicago, Illinois Chief Resident and Instructor Internal Medicine University of Illinois; Chicago, Illinois Medical Oncology/Hematology Fellowship, Memorial Sloan Kettering Cancer Center, New York, New York, New York July 1975 through July 1978 National Leukemia Association Fellow Memorial Sloan-Kettering Cancer Center: New York, New York July 1976 to June 1978 Attending Physician, Clinician I, Department of Medicine A Roswell Park Memorial Institute; New York: June, 1978 to 1979 Research Assistant Professor, Department of Medicine University of South Florida School of Medicine September 1980 to 2000 Affiliate Physician Moffitt Cancer Center, Tampa, Fl present Certification and Licensure Licensed to practice in Florida Florida License #ME Diplomate of Internal Medicine June, 1975 Diplomate of Medical Oncology - June, 1979 Fellow of the American College of Physicians April, 1981 Full Member, American Society of Blood and Marrow Transplantation 1995 Member, Solid Tumor Panel 1997 Biographic Appointments Who s Who in Frontier Science and Technology: 1984 Who s Who in the South and Southwest Affiliations American Society of Clinical Oncology American Society of Internal Medicine Robert L. Drapkin, M.D., FACP Curriculum vitae

3 National committees Clinical Practice Committee American Society of Clinical Oncology: Hospital Appointments Chief of Department of Internal Medicine Mease Dunedin Hospital and Mease Countryside Hospital, Dunedin, Florida 1988 Chairman of Investigation and New Drugs and Devices Committee Morton Plant Hospital, Florida Current Hospital Affiliations Morton Plant Mease Dunedin Hospital, Dunedin, Florida Morton Plant Mease Countryside Hospital, Clearwater, Florida Morton Plant Hospital Clearwater, Florida Research Grants Mease Hospital Foundation for Cancer Research: and Special Interests Trustee Museum of Fine Arts St. Petersburg, Florida-Board of Directors Board of Directors Florida Museum of Photographic Art, Tampa, Fl present Board of Directors Graphic Studio, USF, Tampa, Fl present Assesions Committee Harvard Fogg Museum Bone Marrow Transplant and Human Peripheral Blood Stem Cell Work Hospice Medical Director, Suncoast Hospice, Pinellas County, Fl., Body Building Competitions-First Place Championships: 2014 Southeastern Competition Men over 70 years 2008 Tampa Classic Open Men Bantam Weight 2005 Southern States Competition Men over 60 years 2004 Tampa Classic Men over 50 years presently training for National Masters in July 2015

4 1) Clinical responsibility under the supervision of Bayard Clarkson, MD at Memorial Sloan-Kettering Cancer Center, New York City, New York 2) Clinical Research on human peripheral blood stem cells with Bayard Clarkson, MD, sponsored by National Cancer Institute at Memorial Sloan- - Kettering Cancer Center, New York City, New York. See Publication #7. 3) Attending physician with bone marrow transplant service responsibility Dept. of Medicine A, Roswell Park Memorial Institute with Edward Henderson, MD. Robert L. Drapkin, M.D., FACP Curriculum vitae 4) 1992 present Co-Founder and Co-Director of the stem cell program at Morton Plant Hospital 5) Publications Numbers 5,7,16,17 6) Member of American Society for Blood and Marrow Transplantation 1996 present 7) Elected Fellow American College of Physicians ) Board Certified Internal Medicine by the American Board of Internal Medicine1975 9) Board Certified Medical Oncology by the American Board of Internal Medicine 1979 Miscellaneous PHARMACEUTICAL INDUSTRY EXPERIENCE: SUPERGEN IND,Protocol Design, and SPEAKER to develop the drug Nipent in Malignant Lymphoma and CLL. Radio Talk Show WSUN 620 AM The Truth About Your Healthcare, Interviews and Call-Ins to 1999 Publications 1. Drapkin, R.L., Otsuka, A.L., Castellanos, H., ElHindi, S., Niwicka, H., and Levitan, R.,: Acquisition of a Pyloric Septum or Pyloric Duodenal Fistula. Gastroenterology 66: pp , Drapkin, R.L., Gee, T., Dowling, M., McKenzie, S., and Clarkson, B.: Prophylactic Heparinization with Daunomycin (Dauno.) and Arabinosylcytosine (Ara-C) in Acute Promyelocytic Leukemia (APL). Proceedings of the Nineteenth Annual Meeting of the American Society of Hematology, Boston, Mass., December, 1976, p. 127 (#222). 3. Drapkin, R.L., Gee, T., Dowling, M., McKenzie, S., and Clarkson, B.: Prophylactic Heparin Therapy in Acute Promyelocytic Leukemia. Cancer 4l: p , Drapkin, R.L., Gee, T.S., Arlin, Z., McKenzie, S., and Clarkson, B.: A Three Year Evaluation of Prophylactic Heparin Therapy During Remission Induction in Acute

5 Promyelocytic Leukemia in Adults. Proceedings, American Society of Clinical Oncology. 19: p. 408, 1978 (#C-405). 5. Drapkin, F.L., Epstein, J., Preisler, H., and Higby, D.: Characterization of Normal Human Myeloid Progenitor Cells in Myeloblast-Promyelocyte Enriched Samples of Normal Bone Marrow. Proceedings of American Association Cancer Research 20: p.215, Drapkin, R.L., Bjornsson, S., Higby, D., Getaz, E.P., Henderson, E.S., Caracnadas, J., Wallens, W.T., Kuberka, N., Suh, S., and Siddiqi, N.: Adriamycin, Diamminedichloroplatinum and C. Parvum in Non-Small Cell Bronchogenic Carcinoma. Proceedings American Society Clinical Oncology 20: p. 349, Drapkin, R.L., Andreeff, M., Koziner, B., Strife, A., Wisniewski, N., Darzynkiewicz, Z., Melamed, M.R., and Clarkson, B.: Sub-populations of Human Peripheral Blood Cells: Analysis of Granulocytic Progenitor Cells by Flow Cytometry and Immunologic Surface Marks. American Journal of Hematology. Pending Drapkin, R.L., Bjornsson, S., Nacher, C., Higby, D., Caracnadas, J., Wallens, W.T., Kuberka, N., Suh, K. Siddiqi, N., And Henderson, E.: Adriamycin, Daimminedichloroplatinum and Corynebacterium Parvum in Non-Small Cell Bronchogenic Carcinoma. Cancer Treatment Reports, March, Drapkin, R.L., Mayor, H., Douglas, H., and Creaven, P.: Sequential Methotrexate (MTX) and 5-Fluorouracil (5FU) in Human Malignant Diseases, A Synergistic Regimen. Proceedings, American Society of Clinical Oncology 21: p. 345, 1980 (#C-104) Robert L. Drapkin, M.D., FACP Curriculum vitae 10. Drapkin, R.L., Paladine, W., Ayres, V., Price, L., Sokol, G., Krim, E. and Scheinbaum, M.: Danazol, An Inhibitor of LH and FSH in the Treatment of Recurrent or Metastatic Breast Carcinoma. Proceedings, American Society of Clinical Oncology 22: p. 447 (#447) 11. Drapkin RL, Griffiths E, McAloon E, Paladine W, Sokol G, Lyman G: Sequential Methotrexate and 5-fluoracil in adenocarcinoma of the colon and rectum. Proc Am Soc Clin Oncol 1981;22:453(#C-471). 12. Drapkin, R.L., McAloon, E., Sokol, G., Paladine, W., Marks, R.: The Antiemetic Effect of Dexamethasone in Patients Receiving Cis-Platinum. Proceedings, American Society of Clinical Oncology 22: p.419, 1981 (#C-685) 13. Drapkin, R.L., Stanton, G., Nealy, R., Bennett, G., Levin, H., Cavanaugh, D.: Sequential Methotrexate, Velban and Cis-Diamminedichloroplatinum in Advanced Ovarian Cancer Refractory to Initial Chemotherapy. Proceedings, American Society of Clinical Oncology. 3: p. 175, 1984 (#C-685) 14. Drapkin, R.L., Cobb, S.M., Nagelkerk, J., Leaverton, P., Osterly, S., McCreary, R., and Stanton, G.: Anxiety Traits and States and Nausea and Vomiting in Patients Receiving Chemotherapy. Proceedings, American Society of Clinical Oncology 5: p.243, Drapkin, R.L., Stanton, G., McCreary, R., McAloon, E., Solomon, E., Lyman, G., Osterly, S., Spielberger, C.D.: State Anxiety, Trait Anxiety and Anger Expression in Oncology Patients Receiving Chemotherapy. Proceedings, American Society of Clinical Oncology. 7: p. 270, 1988 (#1048) 16. Drapkin, R.L., Weaver, C.H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L.S., Kaywin, P., Grant, B., Buchner, C.D.: Engraftment and Outcomes of Patients Receiving Myeloblative Therapy followed by Autologous Peripheral Blood Stem Cells with a Low CD34+Cell Content. Biology of Blood and Marrow Transplantation, February, Drapkin, R.L., Weaver, C.H. Schwartzberg, L.S., Birch, R., Greco, F.A., Hainsworth, J., Campos, L., Grapski, R., Schwerkoske, J., Lautersztain, J., Administration of Paclitaxel, Cyclophosphamide and Filgrastim in Patients with Breast and Ovarian Cancer. Biology of Blood and Marrow Transplantation, February, Demetri, Kris, Wade, Degos, and Cella for the Procrit Study Group: Quality-of-Life Benefit in Chemotherapy Patients Treated with Epoetin Alfa Is Independent of Disease

6 Response or Tumor Type: Results From a Prospective Community Oncology Study. Journal of Clinical Oncology, Vol. 16, No 10 (October), 1998, p Drapkin, R.L., Barolo, J.L.: Effect of Granisetron on Performance Status during High- Dose Interferon Therapy, Oncology, International Journal of Cancer Research and Treatment, November, Drapkin, R., Stanton, G, McCreary, R., Barolo, J.: Phase I/II Trial of Topotecan (T) and Docetaxel (D) as Treatment for Refractory Metastatic Breast Cancer. Proceedings, American Society of Clinical Oncology, 2000, #464, p120a 21. Drapkin, R.: Pentostatin and Rituximab in the Treatment of Patients With B-Cell Malignancies. Oncology, June, 2000, Vol. 14 No.6, Supplement No.2 p Drapkin, R.L., Kalman, Leonard A., Birch, Robert, Sysel, Irene Ann, Schwartzberg, Lee S., Peacock, Nancy, Leff, Richard, Santala, Roger, Hainsworth, John: Intensive Induction Chemotherapy Followed by High Dose Alkylator Consolidation With Peripheral Blood Stem Cell Rescue For Patients With Newly Diagnosed High-Grade Non-Hodgkin s Lymphoma. Proceedings, American Society of Clinical Oncology, Drapkin, R.L.: Pentostatin and Rituximab in Follicle Center Lymphomas and Chronic Lymphocytic Leukemia, Abstract #77, Presented at the 18 th Annual Mount Sinai School of Medicine s Chemotherapy Foundation Symposium. Nov 8-11, New York